RÉSUMÉ
This cohort study assesses the incidence of conjunctival melanoma, associations between demographic factors, and trends over time in the US.
Sujet(s)
Tumeurs de la conjonctive , Mélanome , Humains , Incidence , Tumeurs de la conjonctive/épidémiologie , Mélanome/épidémiologieRÉSUMÉ
A pandemic outbreak of a viral respiratory infection (COVID-19) caused by a coronavirus (SARS-CoV-2) prompted a multitude of research focused on various aspects of this disease. One of the interesting aspects of the clinical manifestation of the infection is an accompanying ocular surface viral infection, viral conjunctivitis. Although occasional reports of viral conjunctivitis caused by this and the related SARS-CoV virus (causing the SARS outbreak in the early 2000s) are available, the prevalence of this complication among infected people appears low (~1%). This is surprising, considering the recent discovery of the presence of viral receptors (ACE2 and TMPRSS2) in ocular surface tissue. The discrepancy between the theoretically expected high rate of concurrence of viral ocular surface inflammation and the observed relatively low occurrence can be explained by several factors. In this work, we discuss the significance of natural protective factors related to anatomical and physiological properties of the eyes and preventing the deposition of large number of virus-loaded particles on the ocular surface. Specifically, we advance the hypothesis that the standing potential of the eye plays an important role in repelling aerosol particles (microdroplets) from the surface of the eye and discuss factors associated with this hypothesis, possible ways to test it and its implications in terms of prevention of ocular infections.
Sujet(s)
Betacoronavirus , Conjonctivite virale/prévention et contrôle , Infections à coronavirus/prévention et contrôle , Oeil/virologie , Modèles biologiques , Pandémies/prévention et contrôle , Pneumopathie virale/prévention et contrôle , Aérosols , Microbiologie de l'air , Betacoronavirus/pathogénicité , COVID-19 , Conjonctivite virale/virologie , Infections à coronavirus/transmission , Infections à coronavirus/virologie , Humains , Potentiels de membrane , Phénomènes physiologiques oculaires , Taille de particule , Pneumopathie virale/transmission , Pneumopathie virale/virologie , SARS-CoV-2 , Électricité statiqueRÉSUMÉ
Mutations in the Pax6 gene cause ocular defects in both vertebrate and invertebrate animal species, and the disease aniridia in humans. Despite extensive experimentation on this gene in multiple species, including humans, we still do not understand the earliest effects on development mediated by this gene. This prompted us to develop pax6 mutant lines in Xenopus tropicalis taking advantage of the utility of the Xenopus system for examining early development and in addition to establish a model for studying the human disease aniridia in an accessible lower vertebrate. We have generated mutants in pax6 by using Transcription Activator-Like Effector Nuclease (TALEN) constructs for gene editing in X. tropicalis. Embryos with putative null mutations show severe eye abnormalities and changes in brain development, as assessed by changes in morphology and gene expression. One gene that we found is downregulated very early in development in these pax6 mutants is myc, a gene involved in pluripotency and progenitor cell maintenance and likely a mediator of some key pax6 functions in the embryo. Changes in gene expression in the developing brain and pancreas reflect other important functions of pax6 during development. In mutations with partial loss of pax6 function eye development is initially relatively normal but froglets show an underdeveloped iris, similar to the classic phenotype (aniridia) seen in human patients with PAX6 mutations. Other eye abnormalities observed in these froglets, including cataracts and corneal defects, are also common in human aniridia. The frog model thus allows us to examine the earliest deficits in eye formation as a result of pax6 lesions, and provides a useful model for understanding the developmental basis for the aniridia phenotype seen in humans.
Sujet(s)
Aniridie/embryologie , Aniridie/génétique , Protéines de l'oeil/génétique , Protéines de l'oeil/physiologie , Protéines à homéodomaine/génétique , Protéines à homéodomaine/physiologie , Mutation , Facteurs de transcription PAX/génétique , Facteurs de transcription PAX/physiologie , Protéines de répression/génétique , Protéines de répression/physiologie , Xenopus/embryologie , Xenopus/génétique , Animaux , Aniridie/anatomopathologie , Séquence nucléotidique , Codon non-sens , ADN/génétique , Modèles animaux de maladie humaine , Exons , Oeil/embryologie , Oeil/croissance et développement , Ciblage de gène , Humains , Données de séquences moléculaires , Mutagenèse , Facteur de transcription PAX6 , Facteurs de transcription PAX/déficit , Phénotype , Protéines de répression/déficit , Spécificité d'espèceRÉSUMÉ
Homeostasis is essential for cell survival. However, homeostatic regulation of surface epithelia is poorly understood. The eye surface, lacking the cornified barrier of skin, provides an excellent model. Tears cover the surface of the eye and are deficient in dry eye, the most common eye disease affecting at least 5% of the world's population. Only a tiny fraction of the tear proteome appears to be affected, including lacritin, an epithelium-selective mitogen that promotes basal tearing when topically applied to rabbit eyes. Here we show that homeostasis of cultured corneal epithelia is entirely lacritin-dependent and elucidate the mechanism as a rapid autophagic flux to promptly restore cellular metabolism and mitochondrial fusion in keeping with the short residence time of lacritin on the eye. Accelerated flux appears to be derived from lacritin-stimulated acetylation of FOXO3 as a novel ligand for ATG101 and coupling of stress-acetylated FOXO1 with ATG7 (which remains uncoupled without lacritin) and be sufficient to selectively divert huntingtin mutant Htt103Q aggregates largely without affecting non-aggregated Htt25Q. This is in keeping with stress as a prerequisite for lacritin-stimulated autophagy. Lacritin targets the cell surface proteoglycan syndecan-1 via its C-terminal amino acids Leu(108)-Leu(109)-Phe(112) and is also available in saliva, plasma, and lung lavage. Thus, lacritin may promote epithelial homeostasis widely.